why choose us

First received: September 26, 2023

Clinical Trial: A Study of Felzartamab in Participants With Lupus Nephritis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lupus Nephritis

Study Type: INTERVENTIONAL


Official Title: An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis

Brief Summary: The goal of this clinical trial is to evaluate the safety and tolerability of felzartamab plus standard of care in participants with refractory Lupus Nephritis (LN).

Read more